ミシシッピ州における転移性癌の臨床試験
ミシシッピ州内の拠点で、転移性癌に関する6件の研究が参加者を募集しています。
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
- Baptist Cancer Center-Grenada, Grenada
- Baptist Memorial Hospital and Cancer Center-Union County, New Albany
- 他2件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Hattiesburg Clinic Hematology/Oncology, Hattiesburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- North Mississippi Hematology and Oncology Associates, Tupelo
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- North Mississippi Hematology and Oncology Associates, Tupelo
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581Collection and Storage of Tissue and Blood Samples From Patients With Cancer
- Baptist Memorial Hospital and Cancer Center-Oxford, Oxford
被験者募集中観察研究
2 Months · 全性別 · 2026/03/05更新 · NCT02474160SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hattiesburg
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。